D.E. Shaw & Co
AVAH icon

D.E. Shaw & Co’s Aveanna Healthcare AVAH Stock Holding History

D.E. Shaw & Co’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-405,065
Closed -$316K – 4420
2022
Q4 		$316K Sell
405,065
-4,038
-1% -$4.22K ﹤0.01% 4065
2022
Q3 		$614K Buy
409,103
+22,950
+6% +$47.2K ﹤0.01% 3907
2022
Q2 		$873K Buy
386,153
+14,086
+4% +$40.8K ﹤0.01% 3725
2022
Q1 		$1.27M Buy
372,067
+222,608
+149% +$1.21M ﹤0.01% 3714
2021
Q4 		$1.11M Sell
149,459
-75,891
-34% -$551K ﹤0.01% 3845
2021
Q3 		$1.81M Buy
225,350
+124,830
+124% +$1.21M ﹤0.01% 3132
2021
Q2 		$1.24M Buy
+100,520
New +$1.19M ﹤0.01% 3361

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $233M AUM 18.82% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

D.E. Shaw & Co's AVAH Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Aveanna Healthcare (AVAH) in Q1 2023, closing a stake of 405,065 shares — an estimated $316K sold.

D.E. Shaw & Co first reported a position in AVAH in Q2 2021 and held it in 7 quarters. The position peaked at $1.81M in Q3 2021. 68 funds tracked by Wall St. Rank hold AVAH as of Q1 2023.

  • D.E. Shaw & Co reported no remaining Aveanna Healthcare position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 405,065 Aveanna Healthcare shares in Q1 2023, an estimated $316K.
  • D.E. Shaw & Co first reported a position in Aveanna Healthcare in Q2 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's Aveanna Healthcare position peaked at $1.81M in Q3 2021.
  • 68 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.